Market Access/ News/ News/ News/ R&D US senators blast Novartis for Zolgensma data falsification George Underwood fda, gene therapy, Navartis, pricing, spinal muscular atrophy, Zolgensma 0 Comment US politicians have urged the FDA to come down hard on Novartis for failing to disclose manipulated data Share X US senators blast Novartis for Zolgensma data falsification https://pharmaphorum.com/news/us-senators-blast-novartis-for-zolgensma-data-falsification/
fda, gene therapy, Navartis, pricing, spinal muscular atrophy, Zolgensma
0 Comment
